| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Medica
| Facility | $1,258.93 | $4,073.80 | $4,073.80 | |
United
| Professional | $602.56 | $707.95 | $1,023.29 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Medica
| Facility | $1,258.93 | $4,073.80 | $4,073.80 | |
United
| Professional | $602.56 | $707.95 | $1,023.29 |